Chu X, Tian W, Wang Z, Zhang J, Zhou R. Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials. Mol Cancer. 2023 Jun 8;22(1):93. doi: 10.1186/s12943-023-01800-3. PMID: 37291608. (JCR1区 IF=41.44)
发布时间：2023-06-09
点击次数：
是否译文：否
上一条： Chu X, Niu L, Yang X, He S, Li A, Chen L, Liang Z, Jing D, Zhou R#. Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial. iScience. 2023 Sep 15;26(9):107634. doi: 10.1016/j.isci.2023.107634 (JCR1区 IF=6.11)
下一条： Niu L, Chu X, Yang X, et al. A multiomics approach-based prediction of radiation pneumonia in lung cancer patients: impact on survival outcome [published online ahead of print, 2023 May 8]. J Cancer Res Clin Oncol. 2023;10.1007/s00432-023-04827-7. doi:10.1007/s00432-023-04827-7 (JCR2区 IF=4.55)